Daniel Azorín
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Daniel Azorín has a total of 134 co-authors. Here are the top co-authors by number of shared publications:
- Antonio Torrelo
Department of Dermatology Hospital Infantil Universitario Niño Jesús Madrid Spain
4 shared publications - Isabel Colmenero
Department of Pathology Hospital Infantil Niño Jesús Madrid Spain
3 shared publications - Angela Hernandez-Martin
Department of Dermatology Hospital Infantil Universitario Niño Jesús Madrid Spain
2 shared publications Antonio Torrelo
Department of Dermatology, Hospital Infantil del Niño Jesús, Madrid, Spain
2 shared publications- Beatriz Corredor Andrés
Servicio de Pediatría, Hospital Infantil Universitario Niño Jesús, Madrid, Spain
2 shared publications Claudio Ballestín
2 shared publications
Latest Publications
- 14 May 2026
- Published by SAGE Publications in International Journal of Surgical Pathology
- Vol. 34 (7) , 1819-1824
Atypical Neurofibromatous Neoplasms of Uncertain Biological Potential in Children with Neurofibromatosis Type 1: Report of Two Patients and Review
Atypical neurofibromatous neoplasm of uncertain biological potential (ANNUBP) lies between plexiform neurofibroma and malignant peripheral nerve sheath tumor (MPNST) in neurofibromatosis type 1 (NF1). Pediatric data are limited. We report two children with NF1 and rapidly enlarging peripheral nodules. Patient 1: a 13-year-old boy developed a lumbogluteal nodule despite prior selumetinib. Ultrasound showed a hypoechoic lesion with vascularity; magnetic resonance imaging confirmed interval growth. Excision revealed hypercellularity, architectural loss, cytologic atypia, and up to 2 mitotic figures/10 high-power fields. Immunohistochemistry showed S100/SOX10 positivity, focal CD34 loss, p16 loss, p53 wild-type pattern, and Ki-67 ≈1% overall, consistent with ANNUBP. Patient 2: a 15-year-old girl had a painful mass on the volar forearm. Resection disclosed a tumor embedded with a median-nerve fascicle. Histology showed hypercellularity, architectural loss, and 1 mitotic figure/10 high-power fields without necrosis; Immunohistochemistry showed S100, focal CD34/p16 reduction, and Ki-67 < 1%. Both patients remain recurrence-free under risk-adapted surveillance. ANNUBP is defined by ≥2 of atypia, hypercellularity, architectural loss, and low-level mitotic figures. Frameworks integrate morphology with CDKN2A/B and emphasize retained H3K27me3 to distinguish ANNUBP from MPNST. In children, ultrasound, magnetic resonance imaging, and positron emission tomograph support triage and biopsy. When feasible, complete excision is preferred; unresectable lesions need closer imaging. Early recognition widens cure opportunities and may refine risk stratification.
- 14 May 2026
- Published by SAGE Publications in International Journal of Surgical Pathology
- Vol. 34 (7) , 1819-1824
Atypical Neurofibromatous Neoplasms of Uncertain Biological Potential in Children with Neurofibromatosis Type 1: Report of Two Patients and Review
Atypical neurofibromatous neoplasm of uncertain biological potential (ANNUBP) lies between plexiform neurofibroma and malignant peripheral nerve sheath tumor (MPNST) in neurofibromatosis type 1 (NF1). Pediatric data are limited. We report two children with NF1 and rapidly enlarging peripheral nodules. Patient 1: a 13-year-old boy developed a lumbogluteal nodule despite prior selumetinib. Ultrasound showed a hypoechoic lesion with vascularity; magnetic resonance imaging confirmed interval growth. Excision revealed hypercellularity, architectural loss, cytologic atypia, and up to 2 mitotic figures/10 high-power fields. Immunohistochemistry showed S100/SOX10 positivity, focal CD34 loss, p16 loss, p53 wild-type pattern, and Ki-67 ≈1% overall, consistent with ANNUBP. Patient 2: a 15-year-old girl had a painful mass on the volar forearm. Resection disclosed a tumor embedded with a median-nerve fascicle. Histology showed hypercellularity, architectural loss, and 1 mitotic figure/10 high-power fields without necrosis; Immunohistochemistry showed S100, focal CD34/p16 reduction, and Ki-67 < 1%. Both patients remain recurrence-free under risk-adapted surveillance. ANNUBP is defined by ≥2 of atypia, hypercellularity, architectural loss, and low-level mitotic figures. Frameworks integrate morphology with CDKN2A/B and emphasize retained H3K27me3 to distinguish ANNUBP from MPNST. In children, ultrasound, magnetic resonance imaging, and positron emission tomograph support triage and biopsy. When feasible, complete excision is preferred; unresectable lesions need closer imaging. Early recognition widens cure opportunities and may refine risk stratification.
- Open Access
- 31 May 2024
- Published by Elsevier in Journal of Pediatric Surgery Open
- Vol. 8
Non-Wilms renal tumors: Twenty years experience in a referral center
- 31 May 2024
- Published by Elsevier in Journal of Pediatric Surgery Open
- Vol. 8
Open AccessNon-Wilms renal tumors: Twenty years experience in a referral center
- 1 January 2024
- Published by Wolters Kluwer Health in JBJS Case Connector
- Vol. 14 (1)
Hexapod Frame Correction of Proximal Tibial Recurvatum Caused Indirectly by a Femoral Aneurysmal Bone Cyst in an Adolescent
Case: A 16-year-old boy presented with a recurrent distal femur aneurysmal bone cyst accompanied by a combined sagittal knee deformity (20° of femoral antecurvatum and 26.8° of tibial recurvatum) and limb shortening. After preoperative planning, the treatment involved new intralesional curettage, phenolization, and bone allograft filling. Additional procedures included distal extension femoral osteotomy with plate fixation, and proximal tibial osteotomy with, gradually corrected through a hexapod frame. At 2-year follow-up, lower limbs exhibited normoalignment and equal length. Conclusion: Complex knee deformities may occur with tumoral lesions around the knee but can be effectively addressed through double osteotomy and application of a hexapod frame.
- 1 January 2024
- Published by Wolters Kluwer Health in JBJS Case Connector
- Vol. 14 (1)
Hexapod Frame Correction of Proximal Tibial Recurvatum Caused Indirectly by a Femoral Aneurysmal Bone Cyst in an Adolescent
Case: A 16-year-old boy presented with a recurrent distal femur aneurysmal bone cyst accompanied by a combined sagittal knee deformity (20° of femoral antecurvatum and 26.8° of tibial recurvatum) and limb shortening. After preoperative planning, the treatment involved new intralesional curettage, phenolization, and bone allograft filling. Additional procedures included distal extension femoral osteotomy with plate fixation, and proximal tibial osteotomy with, gradually corrected through a hexapod frame. At 2-year follow-up, lower limbs exhibited normoalignment and equal length. Conclusion: Complex knee deformities may occur with tumoral lesions around the knee but can be effectively addressed through double osteotomy and application of a hexapod frame.
- 1 January 2023
- Published by Elsevier in Reumatología Clínica
- Vol. 19 (1) , 53-56
Fatal Pulmonary Veno-Occlusive Disease and Systemic Juvenile Idiopathic Arthritis: Case Report and Literature Review
- 1 January 2023
- Published by Elsevier in Reumatología Clínica
- Vol. 19 (1) , 53-56
Fatal Pulmonary Veno-Occlusive Disease and Systemic Juvenile Idiopathic Arthritis: Case Report and Literature Review
- Open Access
- 1 December 2018
- Published by Elsevier in Anales de Pediatría
- Vol. 89 (6) , 383-385
Fibroadenoma gigante de mama en adolescentes: procedimientos diagnóstico-terapéuticos
- 1 December 2018
- Published by Elsevier in Anales de Pediatría
- Vol. 89 (6) , 383-385
Open AccessFibroadenoma gigante de mama en adolescentes: procedimientos diagnóstico-terapéuticos
- Open Access
- 13 February 2018
- Published by Elsevier in Anales de Pediatría
- Vol. 89 (5) , 309-311
Hiperplasia estromal seudoangiomatosa mamaria bilateral
- 13 February 2018
- Published by Elsevier in Anales de Pediatría
- Vol. 89 (5) , 309-311
Open AccessHiperplasia estromal seudoangiomatosa mamaria bilateral
- 1 February 2017
- Published by Elsevier in Cancer Letters
- Vol. 386, 196-207
DNA methylation profiling identifies PTRF/Cavin-1 as a novel tumor suppressor in Ewing sarcoma when co-expressed with caveolin-1
- 1 February 2017
- Published by Elsevier in Cancer Letters
- Vol. 386, 196-207
DNA methylation profiling identifies PTRF/Cavin-1 as a novel tumor suppressor in Ewing sarcoma when co-expressed with caveolin-1
- Open Access
- 26 August 2016
- Published by Impact Journals, LLC in Oncotarget
- Vol. 7 (37) , 58759-58767
Efficacy of ATR inhibitors as single agents in Ewing sarcoma
Efficacy of ATR inhibitors as single agents in Ewing sarcoma
- 26 August 2016
- Published by Impact Journals, LLC in Oncotarget
- Vol. 7 (37) , 58759-58767
Open AccessEfficacy of ATR inhibitors as single agents in Ewing sarcoma
Efficacy of ATR inhibitors as single agents in Ewing sarcoma
- 1 October 2015
- Published by Elsevier in Anales de Pediatría
- Vol. 83 (4) , 279-280
Histiocitosis de células de Langerhans con afectación gastrointestinal
- 1 October 2015
- Published by Elsevier in Anales de Pediatría
- Vol. 83 (4) , 279-280
Histiocitosis de células de Langerhans con afectación gastrointestinal
- 30 June 2015
- Published by Taylor & Francis in Fetal and Pediatric Pathology
- Vol. 34 (5) , 315-321
Primary Cutaneous Ewing Sarcoma: Report of a Case
Primary cutaneous Ewing's sarcoma is a rare entity. Although the diagnosis may be very difficult, it can be confirmed through molecular biology. We present the case of a 13-years old male with a lesion in the sole of the right foot, characterized by a monomorphous proliferation of small, round and blue cells. The histology and molecular biology allowed us to perform the diagnosis of cutaneous Ewing's sarcoma. This neoplasm must be distinguished from other round cell tumors with cutaneous involvement. The prognosis and treatment of this rare disease will also be discussed.
- 30 June 2015
- Published by Taylor & Francis in Fetal and Pediatric Pathology
- Vol. 34 (5) , 315-321
Primary Cutaneous Ewing Sarcoma: Report of a Case
Primary cutaneous Ewing's sarcoma is a rare entity. Although the diagnosis may be very difficult, it can be confirmed through molecular biology. We present the case of a 13-years old male with a lesion in the sole of the right foot, characterized by a monomorphous proliferation of small, round and blue cells. The histology and molecular biology allowed us to perform the diagnosis of cutaneous Ewing's sarcoma. This neoplasm must be distinguished from other round cell tumors with cutaneous involvement. The prognosis and treatment of this rare disease will also be discussed.